The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
for autoimmune diseases these are diseases where we do know that there are immune cells going after our own tissue in various ways lupus people are talking about various engineered te- cell trials for rheumatoid arthritis for childhood diabetes for multiple sclerosis um and on and on but those are a number that people are thinking about different types of immunotherapies including gene and edited te cells to treat these autoimmune diseases.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.